GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncopeptides ONCO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.82

+4.60%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Oncopeptides annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 71.1mSEK 31.6mSEK 35.2mSEK 8.4mSEK 118.3m
Operating income−SEK 228.9m−SEK 283.5m−SEK 253.4m−SEK 349.4m−SEK 1.42bn
Net income−SEK 249.6m−SEK 284.6m−SEK 249.1m−SEK 338.0m−SEK 1.43bn
Free cash flow−SEK 222.9m−SEK 260.9m−SEK 279.6m−SEK 423.0m−SEK 1.52bn
Total assetsSEK 134.8mSEK 244.2mSEK 238.4mSEK 385.3mSEK 439.4m
Shareholders' equity−SEK 58.9mSEK 54.3mSEK 56.8mSEK 294.3mSEK 210.9m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.